Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: Is there a role for dietary coenzyme Q?

Journal of Applied Physiology

Volumn 107, Issue 3, 2009, Pages 707-717

  Cano, Ainara ^b   Ciaffoni, Fiorella ^c   Safwat, Ghada M ^c   Aspichueta, Patricia ^b   Ochoa, Begoña ^b   Bravo, Elena ^c   Botham, Kathleen M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Apolipoprotein B; Hepatic steatosis; Microsomal membrane lipids; Microsomal triacylglycerol transfer protein; Triacylglycerol; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN B48; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; MESSENGER RNA; OLIVE OIL; TRIACYLGLYCEROL; UBIQUINONE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; LIPID DIET; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITIONAL ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; RAT;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS B; DIET; FATTY LIVER; LIPID METABOLISM; LIPOPROTEINS, VLDL; LIVER; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UBIQUINONE;

EID: 69749097150     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00297.2009     Document Type: Article

References (49)

1. Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet Med 22: 1129-1133, 2005. (Pubitemid 41224168)
2. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Häkkinen A, Olofsson SO, Yki-Järvinen H, Borén J. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49: 755-765, 2006. (Pubitemid 43357551)
3. Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Järvinen H, Taskinen MR, Borén J. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 50: 2356-2365, 2007. (Pubitemid 47512396)
4. Athar H, Iqbal J, Jiang XC, Hussain MM. A simple, rapid, and sensitive fluorescence assay for microsomal triglyceride transfer protein. J Lipid Res 45: 764-772, 2004. (Pubitemid 38405684)
5. Avramoglu RK, Basciano H, Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 368: 1-19, 2006. (Pubitemid 43776015)
6. Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 7, Suppl: S41-S50, 2007.
7. Bhagavan HN, Chopra RK. Coenzyme Q10: Absorbtion, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40: 445-453, 2006.
8. Bligh Dyer WJ EG. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
9. Bovicelli P, Antonioletti R, Borioni G, Fabbrini D, Barontini M. New efficient synthesis of ubiquionones. Synthetic Commun 38: 391-400, 2008.
10. Brunt E. Non-alcoholic steatohepatitis. Semin Liver Dis 24: 3-20, 2004.
11. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in non-alcoholic steatohepatitis. Hepatology 53: 898-904, 2002.
12. Choi CS, Savage DB, Kulkarni A, Yu XX, Liu ZX, Morino K, Kim S, Distefano A, Samuel VT, Neschen S, Zhang D, Wang A, Zhang XM, Kahn M, Cline GW, Pandey SK, Geisler JG, Bhanot S, Monia BP, Shulman GI. Suppression of diacylglycerol acyl transferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J Biol Chem 282: 22678-22688, 2007. (Pubitemid 47267336)
13. Cuchel M, Bloedon LT, Szapary Kolansky DM PO, Wolfe ML, Sarkis A, Millar JS, Ikewaki K, Siegelman ES, Gregg RE, Rader DJ. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med 356: 148-156, 2007. (Pubitemid 46089675)
14. Davidson NO, Shelness GS. Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu Rev Nutr 20: 169-193, 2000.
15. de Oliveira CP, Simplicio FI, de Lima VM, Yuahasi K, Lopasso FP, Alves VA, Abdalla DS, Carrilho FJ, Laurindo FR, de Oliveira MG. Oral administration of S-nitroso-N-acetyl cysteine prevents the onset of non-alcoholic fatty liver disease in rats. World J Gastroenterol 28: 1905-1911, 2006.
16. Eaton S, Zaitoun AM, Record CO, Bartlett K. β-Oxidation in human alcoholic and non-alcoholic hepatic steatosis. Clin Sci (Lond) 90: 307-313, 1996. (Pubitemid 126425350)
17. Friedewald WT, Levy RI, Frederickson OS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
18. Gibbons GF, Wiggins D, Brown AM, Hebbachi AM. Synthesis and function of hepatic very-low-density lipoprotein. Biochem Soc Trans 32: 59-64, 2004. (Pubitemid 38283014)
19. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem 19: 491-504, 2007.
20. Hebbachi A, Gibbons GF. Inactivation of microsomal triglyceride transfer protein impairs the normal redistribution but not the turnover of newly synthesized glycerolipid in the cytosol, endoplasmic reticulum and Golgi of primary rat hepatocytes. Biochim Biophys Acta 1441: 36-50, 1999. (Pubitemid 29469435)
21. Huertas JR, Battino M, Lena G, Mataix FG. Changes in mitochondrial and microsomal rat liver coenzyme Q9 and Q10, content induced by dietary fat and endogenous lipid peroxidation. FEBS Lett 287: 89-92, 1991.
22. Hussain MM, Bakillah A. New approaches to target microsomal triglyceride transfer protein. Curr Opin Lipidol 19: 572-578, 2008.
23. Hussain MM, Rava P, Pan X, Dai K, Dougan SK, Iqbal J, Lazare F, Khatun I. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr Opin Lipidol 19: 277-284, 2008. (Pubitemid 351653566)
24. Isusi E, Aspichueta P, Liza M, Hernández ML, Díaz C, Hernández G, Martínez MJ, Ochoa B. Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes. Atherosclerosis 153: 283-294, 2000. (Pubitemid 32120327)
25. Iqbal J, Rudel LL, Hussain MM. Microsomal triglyceride transfer protein enhances cellular cholesteryl esterification by relieving product inhibition. J Biol Chem 283: 19967-19980, 2008.
26. Koteish A, Diehl A. Animal models of steatosis. Semin Liver Dis 21: 89-104, 2001.
27. Leiber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, Ponomarenko A, DeCarli LN. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 79: 502-509, 2004.
28. Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev: CD004996, 2007. (Pubitemid 351820394)
29. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 60: 289-293, 2002. (Pubitemid 35025794)
30. Mesenkamp AR, Havekes LM, Romijn JA, Kuipers F. Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E. J Hepatol 35: 816-822, 2001. (Pubitemid 34717676)
31. Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz C, Hussain MM, Alberti A. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 130: 1661-1669, 2006. (Pubitemid 43668848)
32. Olofsson SO, Asp L, Boren J. The assembly and secretion of apolipoprotein B-containing lipoproteins. Curr Opin Lipidol 10: 341-346, 1999. (Pubitemid 29419691)
33. Ohvo-Rekilä H, Ramstedt B, Leppimäki P, Slotte JP. Cholesterol interactions with phospholipids in membranes. Progr Lipid Res 41: 66-97, 2002.
34. Pamplona R. Membrane phospholipids, lipoxidative damage and molecular intergrity: a causal role in aging and longevity. Biochim Biophys Acta 1777: 1249-1262, 2008.
35. Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest 113: 1277-1287, 2004. (Pubitemid 39069927)
36. Partin JS, Partin JC, Schubert WK, McAdams AJ. Liver ultrastructure in abetalipoproteinemia: evolution of micronodular cirrhosis. Gastroenterology 67: 107-118, 1974.
37. Petrosillo G, Portincasa P, Grattagliano I, Casanova G, Matera M, Ruggiero FM, Ferri D, Paradies G. Mitochondrial dysfunction in rat with non alcoholic fatty liver. Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta 1767: 1260-1267, 2007. (Pubitemid 47498313)
38. Rudel LL, Lee RG, Parini P. ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia. Arterioscler Thromb Vasc Biol 25: 1112-1118, 2005. (Pubitemid 40776596)
39. Ruiz JI, Ochoa B. Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis. J Lipid Res 38: 1482-1489, 1997. (Pubitemid 27332574)
40. Safwat GM, Pisanò S, D'Amore E, Borioni G, Napolitano M, Kamal AA, Ballanti P, Botham KM, Bravo E. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect? Nutrition. In press.
41. Sugimoto T, Yamashita S, Ishigami M, Sakai N, Hirano K, Tahara M, Matsumoto K, Nakamura T, Matsuzawa Y. Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats. J Hepatol 36: 157-162, 2002. (Pubitemid 34146421)
42. Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, Marzioni M, De Minicis S, Nobili L, Salzano R, Omenetti A, Pacetti D, Sigmund S, Benedetti A, Casini AA. A model of insulin resistance and nonalcoholic steatohepatitis in rats. Am J Pathol 169: 846-860, 2006.
43. Targher G, Arcado G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 191: 235-240, 2007. (Pubitemid 46400718)
44. Toledo FGS, Sniderman AD, Kelley DE. Influence of hepatic steatosis (fatty liver) on severity and compostion of dyslipidemia in type 2 diabetes. Diabetes Care 29: 1845-1850, 2006.
45. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034, 2002.
46. Vine DF, Takechi R, Russell JC, Proctor SD. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis 190: 282-290, 2007. (Pubitemid 46074043)
47. Watts GF, Gan SK. Nutrition and metabolism: non alcoholic fatty liver diseasepathogenesis, cardiovascular risk and therapy. Curr Opin Lipidol 19: 92-94, 2008.
48. Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, Sanisoglu SY, Erdil A, Ates Y, Aslan M, Musabak U, Erbil MK, Karaeren N, Dagalp K. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 100: 850-855, 2005. (Pubitemid 40592378)
49. Zou Y, Li J, Wang J, Ge J, Huang Y, Zhang L, Wang Y. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci 79: 1100-1107, 2006. (Pubitemid 44102717)